Nicox SA (FR:ALCOX) has released an update.
Nicox SA, an international ophthalmology company, is set to participate in several key industry conferences, including the H.C. Wainwright 4th Annual Ophthalmology Virtual Conference and the 26th Annual Global Investment Conference. The company is known for innovative solutions in the ophthalmology space, with a focus on products like NCX 470 for glaucoma and ZERVIATE for allergic conjunctivitis. Nicox SA is listed on Euronext Growth Paris and is part of the CAC Healthcare index.
For further insights into FR:ALCOX stock, check out TipRanks’ Stock Analysis page.